Results 11 to 20 of about 3,148 (97)

Síndroma de Apneia Obstrutiva do Sono e Doença Cardiovascular – Estudo retrospectivo

open access: yesRevista Portuguesa de Pneumologia, 2003
ABSTRACTIntroduction – Obstructive Sleep Apnea (OSA) is associated with adverse effects in cardiovascular physiology. Some studies have connected this pathology with Cardiovascular Disease (CVD).Aim – Determine the prevalence of CVD in patients with OSA of different severity and verify the association between CVD and OSA.Material and Methods ...
Marta Drummond   +4 more
openaire   +2 more sources

Phase coupling between eye and brain pulsations is bidirectional and modulated by the parasympathetic system – An fMREye study

open access: yesActa Ophthalmologica, Volume 104, Issue 8, Page e1028-e1048, December 2026.
Abstract Purpose Physiological pulsations driven by cardiac, respiratory, and vasomotor activity are essential for solute transport within perivascular and perineural cerebrospinal fluid (CSF) pathways that support brain and eye clearance systems. Previous studies have shown that parasympathetic blockade significantly reduces ocular pulsation power and
Ebrahimi Seyed‐Mohsen   +9 more
wiley   +1 more source

Real‐World Patient Eligibility for Alzheimer's Disease Anti‐Amyloid Therapy in Seven Swedish Memory Clinics

open access: yesEuropean Journal of Neurology, Volume 33, Issue 10, October 2026.
Anti‐amyloid therapies lecanemab and donanemab are targeted at patients with early Alzheimer‐type dementia or mild cognitive impairment (MCI). In a large, Swedish multicenter memory clinic patient cohort, we found an eligibility rate of 11.5% for either treatment in the whole cohort (18.1% among dementia patients, 11.5% among aMCI patients), indicating
Anna Rosenberg   +9 more
wiley   +1 more source

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy

open access: yesAlzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract INTRODUCTION A subset of Alzheimer's disease (AD) patients exhibits a procoagulant state that remains undiagnosed despite available treatments. We developed positron emission tomography (PET) strategies to in vivo detect cerebral microthrombi in TgCRND8 mice. METHODS PET was performed with a fibrin‐binding probe (FBP) in TgCRND8 and wild‐type
Carlos Ceron   +22 more
wiley   +1 more source

First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT This guideline summarizes diagnostic and therapeutic approaches based on a systematic literature review and evidence evaluation using the GRADE methodology. Given the limited high‐quality data, expert consensus was additionally obtained through a modified Delphi process.
Giorgia Olivieri   +26 more
wiley   +1 more source

Prevalence of high‐risk plasma p‐tau217 levels and 5‐year transition of risk status in 70‐year‐olds

open access: yesAlzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION High‐risk plasma p‐tau217 levels predict amyloid‐β pathology in Alzheimer's disease, but little is known about the prevalence and temporal dynamics in the general population. METHODS Participants from the Gothenburg H70 Birth Cohort Study in Sweden were examined (n = 1157) and re‐examined after 5–7 years (n = 771).
Anna Dittrich   +9 more
wiley   +1 more source

Frailty and Health Outcomes in People 65 Years or Older Living With Dementia: A Systematic Review of the Literature

open access: yesJournal of the American Geriatrics Society, Volume 74, Issue 3, Page 854-867, March 2026.
ABSTRACT Introduction Although frailty is considered a potentially modifiable risk factor for dementia, its influence on health outcomes in individuals with established dementia remains unclear. This study aims to systematize the current evidence to understand the impact of frailty on the development of adverse outcomes in older adults with dementia ...
Miguel German Borda   +11 more
wiley   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 2, Page 354-366, February 2026.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu   +9 more
wiley   +1 more source

Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION The sortilin‐related receptor (SORL1) directs APP and Aβ trafficking within the retromer pathway. Cleavage at the cell surface releases soluble SORL1 (sSORL1) into cerebrospinal fluid (CSF). We examined whether CSF‐sSORL1 can serve as an in vivo marker of genetically impaired SORL1.
Matthijs W. J. de Waal   +24 more
wiley   +1 more source

Nursing Interventions for Individuals With Cardiovascular Diseases and Diabetes Mellitus Facing Climate‐Related Environmental Risks: A Scoping Review

open access: yesNursing Forum, Volume 2026, Issue 1, 2026.
With the growing body of scientific evidence on anthropogenic climate change and the increasing awareness of its health impacts, nursing is called to assume a leadership role in addressing climate change as a public health priority. The objective of the study was to map nursing interventions directed at individuals with cardiovascular diseases and ...
Maria Geângela da Silva Oliveira   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy